You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The consortium is comprised of researchers from Inova, Roswell Park Comprehensive Cancer Center, the Mayo Clinic, and MD Anderson Cancer Center.
How labs — including those that are part of other healthcare systems — offering PGx testing will react to Inova's decision to not engage with the FDA remains to be seen.
Pharmacogenetics and legal experts took particular issue with the agency's suggestion that "established" drug/gene relationships are found only in FDA-approved drug labels.
The agency said the MediMap tests are in violation of Federal Food, Drug, and Cosmetic Act because they are intended, in part, for use in disease diagnosis.
NIH and Inova Health System are populating the nascent Genomic Ascertainment Cohort with data from ClinSeq and Inova's longitudinal family study
During a two-year pilot, the Genomic Ascertainment Cohort will collect 10,000 genotypes and make patients available for follow-up exams to confirm predictions.
Inova Translational Medicine Institute has become more efficient running Cloudera's platform, but continues to evaluate this new world of bioinformatics.
Inova Health System is on track to open applications for its Personalized Health Accelerator in July, likely the first such accelerator in the US hosted by a healthcare provider.
Inova plans to offer broad and condition-specific PGx gene panels in its specialty clinics and is negotiating with payors for reimbursement.
Inova is using Translational's platform to evaluate data from MediMap, a new test that evaluates pharmacogenetics markers in seven genes in newborns.
The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.
The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.
Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.
In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.